We are live on
!
Find out more
MCM
Matarin Capital Management Portfolio holdings
AUM
$409M
Turnover
30.94%
1-Year Est. Return
33.03%
This Fund
S&P 500
This Quarter
Est. Return
+4.21%
1 Year Est. Return
+33.03%
3 Year Est. Return
+73.2%
5 Year Est. Return
+181.88%
10 Year Est. Return
–
AUM
$1.08B
AUM Growth
+$63.8M
(+6.3%)
Cap. Flow
+$34.9M
Cap. Flow
% of AUM
3.23%
Top 10 Holdings %
Top 10 Hldgs %
12.6%
Holding
322
New
38
Increased
152
Reduced
64
Closed
47
Avg Time Held
1.1
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eagle Pharmaceuticals, Inc.
EGRX
|
+$8.46M |
| 2 |
Hawaiian Holdings, Inc.
HA
|
+$8.23M |
| 3 |
LM
Legg Mason, Inc.
LM
|
+$7.93M |
| 4 |
CHSP
Chesapeake Lodging Trust
CHSP
|
+$7.89M |
| 5 |
Coca-Cola Consolidated
COKE
|
+$7.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KCG
KCG Holdings, Inc.
KCG
|
+$9.43M |
| 2 |
MGLN
Magellan Health Services, Inc.
MGLN
|
+$8.69M |
| 3 |
ePlus
PLUS
|
+$8.06M |
| 4 |
Murphy USA
MUSA
|
+$7.57M |
| 5 |
Thor Industries
THO
|
+$7.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.53% |
| 2 | Industrials | 15.88% |
| 3 | Technology | 13.74% |
| 4 | Consumer Discretionary | 13.21% |
| 5 | Healthcare | 13.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SHLO
176
DELISTED
Shiloh Industries Inc
SHLO
| $1.27M | 0.12% |
108,315
+78,989
| +269% | +$986K |
2017 Q1
1 quarter
|
|
|
MCF
177
DELISTED
Contango Oil & Gas Co.
MCF
| $1.24M | 0.11% |
185,994
-443
| -0.2% | -$3.09K |
2015 Q3
7 quarters
|
|
178
Marcus & Millichap
MMI
$1.05B
| $1.08M | 0.1% |
41,038
+439
| +1% | +$11K |
2016 Q3
3 quarters
|
|
179
NETGEAR
NTGR
$599M
| $1.08M | 0.1% |
25,014
+780
| +3% | +$35.7K |
2016 Q4
2 quarters
|
|
180
LPL Financial
LPLA
$25.2B
| $1.06M | 0.1% |
25,034
| – | – |
2017 Q1
1 quarter
|
|
181
Photronics
PLAB
$1.65B
| $1.04M | 0.1% |
110,324
+99,174
| +889% | +$1.05M |
2017 Q1
1 quarter
|
|
|
WLB
182
DELISTED
Westmoreland Coal Company
WLB
| $1.01M | 0.09% |
206,539
-36,726
| -15% | -$322K |
2017 Q1
1 quarter
|
|
183
Donnelley Financial Solutions
DFIN
$1.26B
| $1M | 0.09% |
43,608
+826
| +2% | +$18.1K |
2016 Q4
2 quarters
|
|
184
H2O America
HTO
$2.41B
| $985K | 0.09% |
+20,030
| New | +$991K |
2017 Q2
0 quarters
|
|
185
Pebblebrook Hotel Trust
PEB
$2.19B
| $983K | 0.09% |
30,503
+23,473
| +334% | +$731K |
2016 Q4
2 quarters
|
|
|
EXTN
186
DELISTED
Exterran Corporation
EXTN
| $949K | 0.09% |
35,525
+5,442
| +18% | +$154K |
2017 Q1
1 quarter
|
|
187
Amphastar Pharmaceuticals
AMPH
$1.1B
| $936K | 0.09% |
52,417
| – | – |
2017 Q1
1 quarter
|
|
|
LKSD
188
DELISTED
LSC Communications, Inc.
LKSD
| $936K | 0.09% |
43,731
+849
| +2% | +$19.4K |
2016 Q4
2 quarters
|
|
189
NMI Holdings
NMIH
$3.05B
| $921K | 0.09% |
80,440
| – | – |
2017 Q1
1 quarter
|
|
190
Hallador Energy
HNRG
$552M
| $860K | 0.08% |
110,676
+67,581
| +157% | +$507K |
2017 Q1
1 quarter
|
|
191
Peapack-Gladstone Financial
PGC
$767M
| $856K | 0.08% |
27,351
+5,167
| +23% | +$159K |
2016 Q4
2 quarters
|
|
192
Cytokinetics
CYTK
$8.65B
| $846K | 0.08% |
69,882
+49,593
| +244% | +$689K |
2017 Q1
1 quarter
|
|
193
NETSCOUT
NTCT
$2.76B
| $774K | 0.07% |
+22,490
| New | +$814K |
2017 Q2
0 quarters
|
|
194
Tredegar Corp
TG
$271M
| $764K | 0.07% |
50,074
+974
| +2% | +$15.8K |
2016 Q4
2 quarters
|
|
|
VRTV
195
DELISTED
VERITIV CORPORATION
VRTV
| $760K | 0.07% |
16,879
-69,195
| -80% | -$3.18M |
2015 Q1
9 quarters
|
|
196
Nelnet
NNI
$4.56B
| $753K | 0.07% |
16,020
+8,326
| +108% | +$363K |
2016 Q3
3 quarters
|
|
197
Southwest Airlines
LUV
$19.4B
| $753K | 0.07% |
+12,112
| New | +$705K |
2017 Q2
0 quarters
|
|
198
NexPoint Residential Trust
NXRT
$468M
| $749K | 0.07% |
+30,087
| New | +$751K |
2017 Q2
0 quarters
|
|
199
SolarEdge
SEDG
$1.94B
| $748K | 0.07% |
+37,418
| New | +$663K |
2017 Q2
0 quarters
|
|
200
NeoGenomics
NEO
$2.13B
| $719K | 0.07% |
80,233
| – | – |
2017 Q1
1 quarter
|
|
Similar funds
GBBWRPM
PSSGI
RA
TAM
SIVVM
SM
NFG
AWW
Matarin Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Matarin Capital Management held 322 positions worth $1.08B, up 6.3% from $1.02B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Matarin Capital Management deployed $34.9M of net new capital in Q2 2017, opening 38 new positions and adding to 152 existing holdings. Its largest new stake was Eagle Pharmaceuticals, Inc.: 103,444 shares worth $8.16M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Magellan Health Services, Inc., an estimated $8.69M trimmed.
- Matarin Capital Management's largest Q2 2017 buy was Eagle Pharmaceuticals, Inc.: 103,444 shares worth $8.16M.
- Matarin Capital Management added most to Chesapeake Lodging Trust in Q2 2017, an estimated $7.89M increase.
- Matarin Capital Management's biggest Q2 2017 reduction was Magellan Health Services, Inc., cutting an estimated $8.69M.
- Matarin Capital Management fully exited KCG Holdings, Inc. in Q2 2017, selling an estimated $9.43M.
- Matarin Capital Management's ten largest holdings make up 13% of its $1.08B portfolio in Q2 2017.
- Matarin Capital Management opened 38 new positions and closed 47 in Q2 2017.
- Matarin Capital Management's portfolio value rose 6.3% quarter-over-quarter to $1.08B.
Based on Matarin Capital Management's 13F filing for Q2 2017, filed 9 Aug 2017.